Thrombosis and Haemostasis

LinksSchließen

Referenz

Al-Aieshy F, Malmström RE, Antovic J. , et al.
Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.

Eur J Clin Pharmacol 2016;
72 (06) 671-679

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: